[HTML][HTML] From clones to immunopeptidomes: new developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation
E Arrieta-Bolaños - Best Practice & Research Clinical Haematology, 2024 - Elsevier
Mismatching at the HLA-DPB1 locus occurs frequently in hematopoietic cell transplantation
with unrelated donors. Despite this, HLA-DPB1 allelic mismatches have traditionally not …
with unrelated donors. Despite this, HLA-DPB1 allelic mismatches have traditionally not …
Post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated …
BC Shaffer, M Gooptu, TE DeFor, M Maiers… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Access to allogeneic hematopoietic cell transplantation (HCT) remains limited
among persons of non-European ancestry if human leukocyte antigen (HLA) matching is …
among persons of non-European ancestry if human leukocyte antigen (HLA) matching is …
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry
AH Schmidt, J Sauter, J Schetelig, E Neujahr… - Best Practice & …, 2024 - Elsevier
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many
severe blood diseases. As many patients have no suitable family donor, large unrelated …
severe blood diseases. As many patients have no suitable family donor, large unrelated …
Expanding donor options: haploidentical transplant recipients are also highly likely to have a 7/8-matched unrelated donor
The use of haploidentical related donor (HRD) hematopoietic cell transplants (HCTs) in the
United States grew by more than fourfold in the last decade, driven mainly by use of …
United States grew by more than fourfold in the last decade, driven mainly by use of …
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort
MB Hammami, JA Verceles, M Goldfinger… - … and Cellular Therapy, 2024 - Elsevier
Recent advances in graft-versus-host disease (GVHD) prophylaxis including post-transplant
cyclophosphamide (PTCy) and abatacept have significantly improved outcomes following …
cyclophosphamide (PTCy) and abatacept have significantly improved outcomes following …
Unrelated hematopoietic stem cell donor registries: present reality and future prospects
AH Schmidt - Current Opinion in Hematology, 2024 - journals.lww.com
The international community of donor registries, together with the World Marrow Donor
Association, has helped many patients in need of a stem cell transplant over the past …
Association, has helped many patients in need of a stem cell transplant over the past …
Optimized GVHD Prevention in HLA‐Mismatched Unrelated Allogeneic HCT Using a PTCY‐Based Approach
FR Pinto, M Suárez‐Lledó, L Guardia… - European Journal of …, 2024 - Wiley Online Library
Although post‐transplant cyclophosphamide (PTCY)‐based prophylaxis has become a
widely adopted strategy for preventing graft‐versus‐host disease (GVHD) in 9 out of 10 HLA …
widely adopted strategy for preventing graft‐versus‐host disease (GVHD) in 9 out of 10 HLA …
The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDP
SM Devine - Cells, 2024 - mdpi.com
NMDP recognizes that despite advances in hematopoietic stem cell transplantation (HSCT)
and other cell therapies, not all patients have equitable access to treatment, and disparities …
and other cell therapies, not all patients have equitable access to treatment, and disparities …
Donor selection in allogeneic stem cell transplantation
F Barriga, ACM Lima - Current Opinion in Hematology, 2024 - journals.lww.com
Current Opinion in Hematology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
Applying implementation science in the field of transplant and cellular therapy
AM DeSalvo, SR Spellman, JAS Coles, D Robb… - … and Cellular Therapy, 2024 - Elsevier
Implementation science (IS) is a systematic way to approach the broader adoption of
evidence-based practices and has as its goal to understand and address the gap between …
evidence-based practices and has as its goal to understand and address the gap between …